Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
14.34
+0.69 (5.05%)
Nov 21, 2024, 4:00 PM EST - Market closed
Contineum Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 370 | - | - | - |
| Enterprise Value | 156 | - | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.15 | 0.08 |
| Debt / EBITDA Ratio | - | 0.03 | - | - |
| Debt / FCF Ratio | - | 0.03 | - | - |
| Asset Turnover | - | 0.55 | - | - |
| Quick Ratio | 36.84 | 22.83 | 6.26 | 18.78 |
| Current Ratio | 37.06 | 23.29 | 6.41 | 18.99 |
| Return on Equity (ROE) | -20.76% | 27.71% | -48.09% | - |
| Return on Assets (ROA) | -15.32% | 11.10% | -23.44% | - |
| Return on Capital (ROIC) | -15.84% | 11.80% | -25.44% | - |
| Buyback Yield / Dilution | -488.88% | -51.38% | -6.35% | - |
| Total Shareholder Return | -488.88% | -51.38% | -6.35% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.